B04 Effects of nanoliposomal irinotecan (nal-IRI; MM-398) +/- 5-fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy: results from the phase 3 NAPOLI-1 study.
Melisi, D Siveke, J Blanc, J Von Hoff, D Wang-Gillam, A Chen, L Becker, C Mamlouk, K De Jong, F Hubner, Richard A
Melisi, D
Siveke, J
Blanc, J
Von Hoff, D
Wang-Gillam, A
Chen, L
Becker, C
Mamlouk, K
De Jong, F
Hubner, Richard A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016-09-21
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
B04 Effects of nanoliposomal irinotecan (nal-IRI; MM-398) ± 5-fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy: results from the phase 3 NAPOLI-1 study. 2016, 27 (suppl_4): iv18 Annals of Oncology